Literature DB >> 24867507

Is it time to revise the normal range of serum uric acid levels?

G Desideri1, G Castaldo, A Lombardi, M Mussap, A Testa, R Pontremoli, L Punzi, C Borghi.   

Abstract

The actual reference range of serum uric acid has been assessed according to its variations among healthy individuals. i.e. those without clinical evidence of gout. By this approach, serum uric acid values between 3.5 and 7.2 mg/dL in adult males and postmenopausal women and between 2.6 and 6.0 mg/dL in premenopausal women have been identified as normal in many countries. However, this definition of normal range of serum uric acid in the general population is inevitably influenced by what we consider as "normal", since the absence of gout flares does not necessarily imply the absence of uric acid-related damage. Indeed, a growing body of evidence indicates that silent deposition of monosodium urate crystals as a result of hyperuricaemia may occur and lead to early destructive skeletal changes. In addition, a growing body of evidences demonstrates that uric acid might play a pathophysiological role in many "cardio-nephro-metabolic" disorders, which seems to be independent of the deposition of monosodium urate crystals, since it is evident also for serum uric acid concentrations below the saturation point for monosodium urate. Taken together, these findings strongly suggest to carefully reconsider the concept of "asymptomaticity" for chronic hyperuricemia and to consequently revise the normal range of serum uric acid levels also considering the progressive worldwide increase of circulating levels of uric acid, which could lead to a "shift to right" (i.e. toward higher values) of normal range. In the light of the new scientific knowledge on the pathophysiological role of uric acid in human disease, a threshold value < 6.0 mg/dL (< 360 µmol/L) seems to better identify true "healthy subjects" and should reasonably be considered for all subjects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867507

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  65 in total

1.  Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.

Authors:  Giovambattista Desideri; Agostino Virdis; Edoardo Casiglia; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-02-09

2.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

3.  Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Authors:  Maryam Afkarian; Sarit Polsky; Afshin Parsa; Ronnie Aronson; Maria Luiza Caramori; David Z Cherney; Jill P Crandall; Ian H de Boer; Thomas G Elliott; Andrzej T Galecki; Allison B Goldfine; J Sonya Haw; Irl B Hirsch; Amy B Karger; Ildiko Lingvay; David M Maahs; Janet B McGill; Mark E Molitch; Bruce A Perkins; Rodica Pop-Busui; Marlon Pragnell; Sylvia E Rosas; Peter Rossing; Peter Senior; Ronald J Sigal; Catherine Spino; Katherine R Tuttle; Guillermo E Umpierrez; Amisha Wallia; Ruth S Weinstock; Chunyi Wu; Michael Mauer; Alessandro Doria
Journal:  Diabetes Care       Date:  2019-06-11       Impact factor: 19.112

Review 4.  Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Authors:  Francesco Caso; Antonio Del Puente; Francesca Oliviero; Rosario Peluso; Nicolò Girolimetto; Paolo Bottiglieri; Francesca Foglia; Carolina Benigno; Marco Tasso; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

5.  Refining genome-wide associated loci for serum uric acid in individuals with African ancestry.

Authors:  Guanjie Chen; Daniel Shriner; Ayo P Doumatey; Jie Zhou; Amy R Bentley; Lin Lei; Adebowale Adeyemo; Charles N Rotimi
Journal:  Hum Mol Genet       Date:  2020-02-01       Impact factor: 6.150

6.  Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.

Authors:  C Reátegui-Sokolova; Manuel F Ugarte-Gil; Rocío V Gamboa-Cárdenas; Francisco Zevallos; Jorge M Cucho-Venegas; José L Alfaro-Lozano; Mariela Medina; Zoila Rodriguez-Bellido; Cesar A Pastor-Asurza; Graciela S Alarcón; Risto A Perich-Campos
Journal:  Clin Rheumatol       Date:  2017-01-18       Impact factor: 2.980

7.  Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.

Authors:  M V Papavasileiou; A G Karamanou; P Kalogeropoulos; G Moustakas; S Patsianis; A Pittaras
Journal:  J Hum Hypertens       Date:  2015-07-02       Impact factor: 3.012

8.  Association Between the Serum Uric Acid Levels and Lacunar Infarcts in the Elderly.

Authors:  F Crosta; U Occhiuzzi; G Passalacqua; E Occhiuzzi; A Cimini; D Grassi; C Ferri; C Marini; C Borghi; G Desideri
Journal:  J Mol Neurosci       Date:  2018-07-04       Impact factor: 3.444

Review 9.  Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

Authors:  Alessandro Maloberti; C Giannattasio; M Bombelli; G Desideri; A F G Cicero; M L Muiesan; E A Rosei; M Salvetti; A Ungar; G Rivasi; R Pontremoli; F Viazzi; R Facchetti; C Ferri; B Bernardino; F Galletti; L D'Elia; P Palatini; E Casiglia; V Tikhonoff; C M Barbagallo; P Verdecchia; S Masi; F Mallamaci; M Cirillo; M Rattazzi; P Pauletto; P Cirillo; L Gesualdo; A Mazza; M Volpe; G Tocci; G Iaccarino; P Nazzaro; L Lippa; G Parati; R Dell'Oro; F Quarti-Trevano; G Grassi; A Virdis; C Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-10

10.  Enhancement of pharmacological effects of uricosuric agents by concomitant treatment with pyrazinamide in rats.

Authors:  Tetsuya Taniguchi; Naoki Ashizawa; Koji Matsumoto; Takashi Iwanaga
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.